azacitidine has been researched along with Enlarged Spleen in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Kali, A; Alfakara, D; Hashmi, S; Hogan, W; Hook, C; Litzow, M; Patnaik, M; Subari, S; Zblewski, D | 1 |
1 other study(ies) available for azacitidine and Enlarged Spleen
| Article | Year |
|---|---|
Hypomethylating agents are effective in shrinking splenomegaly in patients with chronic myelomonocytic leukemia.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; DNA Methylation; Female; Humans; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Retrospective Studies; Splenomegaly; Treatment Outcome | 2016 |